These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary. Coltman CA Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763 [TBL] [Abstract][Full Text] [Related]
5. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
6. Update on the role of topotecan in the treatment of non-small cell lung cancer. Stewart DJ Oncologist; 2004; 9 Suppl 6():43-52. PubMed ID: 15616149 [TBL] [Abstract][Full Text] [Related]
7. Topotecan in the treatment of non-small cell lung cancer. Perez-Soler R Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-34-S20-41. PubMed ID: 9425959 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy. Khuri FR Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898 [TBL] [Abstract][Full Text] [Related]
11. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
12. New chemotherapy agents in the treatment of advanced non-small cell lung cancer: an update including data from the Seventh World Conference on Lung Cancer. Comis RL; Friedland DM Lung Cancer; 1995 Jun; 12 Suppl 2():S63-99. PubMed ID: 7551951 [TBL] [Abstract][Full Text] [Related]
13. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer. Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771 [TBL] [Abstract][Full Text] [Related]
14. [The status of chemotherapy in non-small-cell bronchial carcinoma]. Drings P; Manegold C Strahlenther Onkol; 1994 Sep; 170(9):495-506. PubMed ID: 7940122 [TBL] [Abstract][Full Text] [Related]
15. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan. Langer CJ Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):19-24. PubMed ID: 11221017 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer. Hillner BE; Smith TJ Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
20. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies]. Langer F; Helsberg K; Schütte WH; Leschinger MI Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]